MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0042349
Aelius Pharma Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹96,750
▼ 100% YoY
Net loss · FY 2025
₹17.86 Lakh
Latest filing
EBITDA · FY 2025
-₹59,587
EBITDA margin -61.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.25 Cr
Issued & subscribed
Open charges
₹1.19 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
8
Provident fund records
About Aelius Pharma Private Limited
Data last updated:
Aelius Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 05 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2013PTC247927. Its GSTIN is 27AAMCA0353K1ZL (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors Karan Raj Kumar and Shalini Karan Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 402 Sai Baba Tower Versova Four Bunglows Andheri (West)Mumbai – 400053, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹96,750, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹17.86 Lakh and EBITDA of -₹59,587 (EBITDA margin -61.6%). Revenue has declined at a compounded annual rate (CAGR) of 86% over three years and 37% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aelius Pharma. As per MCA filings, the company has open charges of ₹1.19 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2019. Its 10 peer companies in the Consumer Products industry (Health and Beauty Retail and Distribution, Healthcare Equipment Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Spiti Foods Private Limited with revenue of ₹1 Lakh.
Aelius Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0042349). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aeliuspharma.com.
Company Details of Aelius Pharma Private Limited
CIN U24233MH2013PTC247927
Registration Number 247927
Incorporation Date 05 September 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0042349
Recognitions & Rankings of Aelius Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address402 Sai Baba Tower Versova Four Bunglows Andheri (West)Mumbai – 400053, Maharashtra, India – 400053
- IndustryHealthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Aelius Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Aelius Pharma Private Limited
Aelius Pharma operates one associated brand: Aelius Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of healthcare, pharmaceuticals, and personal care products in India. | aeliuspharma.com |
Financials of Aelius Pharma Private Limited FY 2025 filings available
Aelius Pharma Private Limited reported revenue of ₹96,750 (down 100% YoY) for FY 2025.
Revenue · FY 2025
₹96,750 ▼ 100%
Net loss · FY 2025
₹17.86 Lakh
EBITDA · FY 2025
-₹59,587 margin -61.6%
Compounded Annual Growth Rate (CAGR) of Aelius Pharma Private Limited
Revenue CAGR growth
3 years · compounded
▼ 86%
5 years · compounded
▼ 37%
EBITDA CAGR growth
1 year
▼ 110%
3 years · compounded
▼ 27%
5 years · compounded
▼ 15%
Revenue has declined at a compounded annual rate (CAGR) of 37% over five years. EBITDA fell 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aelius Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹59,587 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹17.86 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aelius Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -61.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aelius Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aelius Pharma Private Limited
Aelius Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalini Karan Kumar | Additional Director | 21 Mar 2016 | 10 Years 6 Months | Current |
| Karan Raj Kumar | Director | 05 Sep 2013 | 13 Years 1 Months | Current |
Peer Comparison of Aelius Pharma Private Limited
Aelius Pharma Private Limited is compared with the companies closest to it by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Spiti Foods Private Limited | ₹1 Lakh (FY 2019) | •••• | •••• | -99.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Dankos Cosmetics Private Limited | ₹1 Lakh (FY 2017) | •••• | •••• | 67.0% | •••• | Mumbai, Maharashtra, India |
| Adbhut Nirman Private Limited | ₹97,929 (FY 2025) | •••• | •••• | -18.0% | •••• | New Delhi, Delhi, India |
| Boosa Traders Private Limited | ₹97,855 (FY 2019) | •••• | •••• | 43.0% | •••• | Telangana, India |
| Alchemy Consumer Products Private Limited | ₹97,560 (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Aelius Pharma Private Limited this company | ₹96,750 (FY 2025) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Tik Tok Pharma India Private Limited | ₹94,600 (FY 2023) | •••• | •••• | -52.0% | •••• | Delhi, India |
| Marksgeneral Kosmetik Private Limited | ₹94,034 (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Sheberry Retail Private Limited | ₹93,639 (FY 2022) | •••• | •••• | 3059986.0% | •••• | Domjur, West Bengal, India |
| Herbgen Naturals Private Limited | ₹93,363 (FY 2022) | •••• | •••• | 300.0% | •••• | New Delhi, Delhi, India |
| Sai Prayag Pharma Private Limited | ₹93,220 (FY 2025) | •••• | •••• | -73.0% | •••• | Alappuzha, Kerala, India |
Peers are the five companies nearest above and the five nearest below Aelius Pharma by revenue in the Consumer Products industry (Health and Beauty Retail and Distribution, Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aelius Pharma Private Limited
Aelius Pharma Private Limited is audited by VSS & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VSS & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aelius Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aelius Pharma Private Limited
Open charges
₹1.19 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2015 | Others | ₹1.19 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Aelius Pharma Private Limited
Aelius Pharma Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2019.
Total deals
2
Secondary share transfers
2
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Premium access
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Aelius Pharma Private Limited
Aelius Pharma Private Limited has 6 court cases on record: 5 filed by Aelius Pharma, 1 filed against it. 1 case is pending and 5 are disposed. Status as checked between 30 Sep 2026 and 02 Oct 2026.
Total cases
6
Filed by the company
5
Filed against the company
1
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Tribeni Reources Pvt Ltd | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by R. Payal Trading Company | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Aelius Pharma Private Limited
Employment history and EPFO contributions of people linked to Aelius Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aelius Pharma Private Limited
Aelius Pharma Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Shrikant Jagdish Hazare ceased to be Director on 28 Mar 2016.
AGM
Aelius Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aelius Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 1.19 Cr registered on 03 Jun 2015 with Charge ID 10577251 was modified on 18 Dec 2021.
Ceased
Shrikant Jagdish Hazare ceased to be Director.
Appointed
Shalini Karan Kumar was appointed as Additional Director.
Ceased
Sneh Saxena ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.19 Cr with Charge ID 10577251 was registered on 03 Jun 2015.
Ceased
Shalini Karan Kumar ceased to be Director.
Appointed
Karan Raj Kumar was appointed as Director.
Incorporation
05 Sep 2013
Aelius Pharma Private Limited was registered on 05 Sep 2013 with Roc Mumbai & aged 13 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Aelius Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aelius Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aelius Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aelius Pharma Private Limited
Aelius Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCA0353K1ZL | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aelius Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aelius Pharma Private Limited
Aelius Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 05 September 2013 (13+ years old) and is registered under CIN U24233MH2013PTC247927.
Aelius Pharma reported revenue of ₹96,750 for FY 2025 (down 100% YoY).
Aelius Pharma has 2 current directors:
- Shalini Karan Kumar - Additional Director
- Karan Raj Kumar - Director
Aelius Pharma reported a net loss of ₹17.86 Lakh and EBITDA of -₹59,587 (EBITDA margin -61.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aelius Pharma is -86% over three years and -37% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aelius Pharma is 27AAMCA0353K1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aelius Pharma is U24233MH2013PTC247927. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aelius Pharma has 6 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending.
Aelius Pharma was incorporated on 05 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Aelius Pharma has 2 deals on record (2 secondary share transfers); the latest was in March 2019.
The peers of Aelius Pharma by revenue are Spiti Foods Private Limited, Dankos Cosmetics Private Limited, Adbhut Nirman Private Limited, Boosa Traders Private Limited, Alchemy Consumer Products Private Limited and 5 more, all in the Consumer Products industry (Health and Beauty Retail and Distribution, Healthcare Equipment Retail and Distribution).